CN109966417A - 一种针对糖尿病人群的固体饮料 - Google Patents
一种针对糖尿病人群的固体饮料 Download PDFInfo
- Publication number
- CN109966417A CN109966417A CN201711453774.XA CN201711453774A CN109966417A CN 109966417 A CN109966417 A CN 109966417A CN 201711453774 A CN201711453774 A CN 201711453774A CN 109966417 A CN109966417 A CN 109966417A
- Authority
- CN
- China
- Prior art keywords
- parts
- leaf
- moringa
- blood
- bitter buckwheat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 30
- 235000013361 beverage Nutrition 0.000 title claims abstract description 16
- 239000007787 solid Substances 0.000 title claims abstract description 16
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims abstract description 22
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 21
- 241000124033 Salix Species 0.000 claims abstract description 19
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 18
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 18
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 18
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 18
- 244000302512 Momordica charantia Species 0.000 claims abstract description 18
- 235000009811 Momordica charantia Nutrition 0.000 claims abstract description 18
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims abstract description 18
- 235000018365 Momordica dioica Nutrition 0.000 claims abstract description 18
- 240000000249 Morus alba Species 0.000 claims abstract description 18
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 18
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 18
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 18
- 240000008042 Zea mays Species 0.000 claims abstract description 18
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 18
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 18
- 235000005822 corn Nutrition 0.000 claims abstract description 18
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 17
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 17
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 17
- 244000268590 Euryale ferox Species 0.000 claims abstract description 17
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 17
- 235000011347 Moringa oleifera Nutrition 0.000 claims abstract description 14
- 238000004519 manufacturing process Methods 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 240000008620 Fagopyrum esculentum Species 0.000 claims abstract description 5
- 244000179886 Moringa oleifera Species 0.000 claims abstract 4
- 238000003860 storage Methods 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 8
- 239000011812 mixed powder Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 238000007873 sieving Methods 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 2
- 244000025254 Cannabis sativa Species 0.000 claims 1
- 241000382353 Pupa Species 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 44
- 239000008280 blood Substances 0.000 abstract description 44
- 230000000694 effects Effects 0.000 abstract description 38
- 210000003734 kidney Anatomy 0.000 abstract description 15
- 210000004185 liver Anatomy 0.000 abstract description 14
- 210000000952 spleen Anatomy 0.000 abstract description 14
- 230000001976 improved effect Effects 0.000 abstract description 9
- 230000036039 immunity Effects 0.000 abstract description 8
- 230000008901 benefit Effects 0.000 abstract description 5
- 230000009467 reduction Effects 0.000 abstract description 5
- 210000002784 stomach Anatomy 0.000 abstract description 5
- 241000196324 Embryophyta Species 0.000 abstract description 3
- 230000023852 carbohydrate metabolic process Effects 0.000 abstract description 3
- 239000000203 mixture Substances 0.000 abstract description 3
- 235000013311 vegetables Nutrition 0.000 abstract description 2
- 101000976075 Homo sapiens Insulin Proteins 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 abstract 1
- 239000008103 glucose Substances 0.000 description 25
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 23
- 230000002218 hypoglycaemic effect Effects 0.000 description 20
- 241000219051 Fagopyrum Species 0.000 description 17
- 150000002632 lipids Chemical class 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 12
- 241000220215 Moringa Species 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 206010011224 Cough Diseases 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 201000001421 hyperglycemia Diseases 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 244000269722 Thea sinensis Species 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 102000004877 Insulin Human genes 0.000 description 6
- 108090001061 Insulin Proteins 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 229940125396 insulin Drugs 0.000 description 6
- 230000035922 thirst Effects 0.000 description 6
- 210000002700 urine Anatomy 0.000 description 6
- 201000001320 Atherosclerosis Diseases 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 230000035622 drinking Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 206010018473 Glycosuria Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 230000000840 anti-viral effect Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 229930003944 flavone Natural products 0.000 description 4
- 235000011949 flavones Nutrition 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000003862 health status Effects 0.000 description 4
- 235000008216 herbs Nutrition 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000004089 microcirculation Effects 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 150000002213 flavones Chemical class 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 208000030159 metabolic disease Diseases 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000282452 Ailuropoda melanoleuca Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 208000005189 Embolism Diseases 0.000 description 2
- 108010023302 HDL Cholesterol Proteins 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 235000019636 bitter flavor Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 210000000748 cardiovascular system Anatomy 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 201000001352 cholecystitis Diseases 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 208000021735 chronic enteritis Diseases 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- LXBIFEVIBLOUGU-JGWLITMVSA-N duvoglustat Chemical compound OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O LXBIFEVIBLOUGU-JGWLITMVSA-N 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 208000001130 gallstones Diseases 0.000 description 2
- 230000010030 glucose lowering effect Effects 0.000 description 2
- 230000008821 health effect Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000003914 insulin secretion Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- -1 lipid peroxide Chemical class 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 208000018556 stomach disease Diseases 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- CDAISMWEOUEBRE-LKPKBOIGSA-N 1D-chiro-inositol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O CDAISMWEOUEBRE-LKPKBOIGSA-N 0.000 description 1
- SWLAMJPTOQZTAE-UHFFFAOYSA-N 4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]benzoic acid Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(C(O)=O)C=C1 SWLAMJPTOQZTAE-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 229940077274 Alpha glucosidase inhibitor Drugs 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- LXBIFEVIBLOUGU-UHFFFAOYSA-N Deoxymannojirimycin Natural products OCC1NCC(O)C(O)C1O LXBIFEVIBLOUGU-UHFFFAOYSA-N 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 102000051325 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 102000003746 Insulin Receptor Human genes 0.000 description 1
- 108010001127 Insulin Receptor Proteins 0.000 description 1
- 229940122199 Insulin secretagogue Drugs 0.000 description 1
- 229940122355 Insulin sensitizer Drugs 0.000 description 1
- 240000006859 Jasminum officinale Species 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 241000366676 Justicia pectoralis Species 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000031662 Noncommunicable disease Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000003888 alpha glucosidase inhibitor Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 229960002708 antigout preparations Drugs 0.000 description 1
- 210000003056 antler Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000036523 atherogenesis Effects 0.000 description 1
- 238000009412 basement excavation Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 239000003866 digestant Substances 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 230000007849 functional defect Effects 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229950004994 meglitinide Drugs 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明提供了一种针对糖尿病人群的固体饮料，由以下重量份的原料制成：青钱柳叶25‑30，辣木叶20‑25份，葛根15‑20份，山药15‑20份，玉竹12‑18份，苦瓜12‑18份，决明子10‑15份，玉米须10‑15份，蛹虫草8‑12份，桑叶8‑12份，芡实8‑12份，甘草5‑10份，苦荞6‑10份。本发明根据传统配方，以天然药食同源及蔬果植物为原料，配方科学合理，充分发挥组方效果，增强人体胰岛素的活性，加速糖代谢，达到降低、平衡血糖的目的；本发明制作方法简单，操作易行，无副作用，服用方便，长期服用本产品，还具有固肾益本、养肝补脾、补肾益脾、健胃开脾及提高人体免疫力等作用。
Description
技术领域
本发明涉及一种固体饮料，具体涉及一种针对糖尿病人群的固体饮料及其制作方法
背景技术
糖尿病是一组以高血糖为特征的代谢性疾病，而高血糖是由于胰岛素分泌缺陷或其生物作用受损，或两者兼有引起。人体内胰岛素分泌不足，导致糖、蛋白质和水电解质代谢紊乱而引起的疾病，它直接破坏心、脑、肾、眼及神经组织器官，是继肿瘤和心血管疾病之后的较难治愈的第三大非传染性疾病，常常导致碳水化合物，蛋白质，脂肪及水和电解质代谢紊乱造成人体各种组织，特别是脾胃、肾脏、神经、心脏及血管的损伤，功能缺陷和衰竭，糖尿病的发病率和生活方式，饮食结构及年龄因素有关，且随着生活水平提高而呈全面上升之势，糖尿病的发病机制目前仍然不是十分清楚，根据患者显示出的病理学特征：Ι型糖尿病，即胰岛素依赖症，此类型患者必须依赖性胰岛素维持生命；Ⅱ型糖尿病，非胰岛素依赖，患者大多肥胖，胰岛素受体不敏感，占80％以上。
Ⅱ型糖尿病一般受遗传因素、肥胖、饮食及运动不足等影响，导致胰岛素分泌障碍及作用不足而引发的代谢障碍，是一张慢性代谢疾病，其伴随葡萄糖的过剩，体脂肪的分解及蛋白质的浪费，且胰高血糖素的分泌非正常亢进，进而引发代谢紊乱，因此糖尿病导致体内代谢功能异常，出现高血糖症糖通过尿液排出，会导致循环系统的并发症。
治疗糖尿病的首要措施是调节血糖，使其接近正常值，空腹血糖和餐后血糖的调节对糖尿病症状的改善及并发症的预防及治疗非常重要，目前治疗方法主要有药物治疗，常规治疗糖尿病的药物主要是口服药物(磺脲类药物、双胍类降糖药、α葡萄糖苷酶抑制剂、胰岛素增敏剂、格列奈类胰岛素促分泌剂)和长期应用胰岛素治疗，但其均有不同程度的副反应，且用药受限，不能适应现在快节奏的生活。目前市面上也出现了一系列的降糖茶和降糖类保健品，其中降糖茶有效成分含量低，采用传统泡饮方式，利用率低，效果不明显，且不能针对高血糖引起人体内的其它并发症；而降糖保健品中添加中药成分较多，并且还加入部分添加剂，副作用较大，有损器脏，降低人体免疫力，引起其它并发症。
相关检索文献：
[1]《降糖大米》,200710049154.X,2007.05.23。
[2]《降糖茶》,CN 102754710A,2012.10.31。
[3]《降糖茶叶》,CN 103404638A,2013.11.27。
[4]《降糖保健食品》,CN 103859410A,2014.06.18。
[5]《一种降糖茶》,CN 104116848A,2014.10.29。
[6]《降糖降脂茶》,CN 105250664A,2016.01.20。
[7]《一种降糖茶》,CN 105454578A,2016.04.06。
发明内容
本发明的目的是为了缓解和克服上述问题，提供一种高效、安全、针对糖尿病及高血糖人群的降糖固体饮料，通过其有效成分来达到降低、平衡血糖及修复五脏、提高免疫力的目的。
为了达到上述目的，本发明有如下技术方案：
本发明的一种针对糖尿病人群的固体饮料料，它由下述重量份的原料组成：青钱柳叶25-30，辣木叶20-25份，葛根15-20份，山药15-20份，玉竹12-18份，苦瓜12-18份，决明子10-15份，玉米须10-15份，蛹虫草8-12份，桑叶8-12份，芡实8-12份，甘草5-10份，苦荞6-10份。
本发明的一种针对糖尿病人群的固体饮料，其制作方法包括以下步骤：
(1)精选青钱柳叶、辣木叶、葛根、山药、玉竹、苦瓜、决明子、玉米须、蛹虫草、桑叶、芡实、甘草、苦荞，洗净、烘焙制熟后进行超微粉碎，获得200目-300目的超微细粉；
(2)将步骤(1)制成的超微细粉，按重量份的比例称取：青钱柳25-30，辣木叶20-25份，葛根15-20份，山药15-20份，玉竹12-18份，苦瓜12-18份，决明子10-15份，玉米须10-15份，蛹虫草8-12份，桑叶8-12份，芡实8-12份，甘草5-10份，苦荞6-10份，将称量好的超微粉混合好后进行筛分；
(3)将步骤(2)中过筛后的混合粉再经三维混料机进行充分混匀，通过紫外杀菌处理后在无菌环境中进行全密封定量分包装；
(4)将分包装的全密封产品按要求包装成盒，并按照GB/T 29602要求对产品进行检测，合格产品入库储存。
本发明所采用的原料具有以下功效：
青钱柳：味微苦，性温，具有消炎止痛、清热消肿的功效，被誉为植物界的大熊猫，医学界的第三棵树，富含丰富的皂苷、黄酮、多糖等有机营养成分，能够有效平衡人体糖代谢，从而达到降血糖，逆转并发症的养生效果；医学研究发现，青钱柳芽叶含有原生态降糖因子链，其无机营养成分与有机营养成分，能够有效全面的调节人体糖代谢，中医临床用于治疗糖尿病，因其有药理作用能明显降低血糖、减脂肪和尿糖。
辣木叶：纯天然绿色食品，含有丰富的铁、蛋白质、维生素等营养成分，具有抗氧化、通便、利尿、驱虫、改善睡眠等作用，对降血糖、降脂、降压、抗痛风、抗肿瘤等有很好的效果，可协助改善、预防疾病，改善睡眠、增强记忆力、延缓衰老。长期食用可增强人体免疫功能，排毒、塑身、抗老化等，并对多种慢性及重大疾病都有极大的改善功效，可辅助治疗肝脏、脾脏、经络等特殊部位的疾病。
葛根：药食同源，为豆科植物野葛的干燥根，习称野葛，秋、冬二季采挖，趁鲜切成厚片或小块；干燥。性甘、辛，凉，有解肌退热，透疹，生津止渴，升阳止泻之功效，常用于表证发热，项背强痛，麻疹不透，热病口渴，阴虚消渴，热泻热痢，脾虚泄泻。《别录》：疗伤寒中风头痛，解肌发表出汗，开腠理，疗金疮，止胁风痛。
山药：含有丰富的淀粉、蛋白质、无机盐和多种维生素等营养物质，还含有多量纤维素以及胆碱、粘液质等成分，具有降血糖、滋养强壮，助消化，敛虚汗，止泻之功效，主治脾虚腹泻、肺虚咳嗽、糖尿病消渴、小便短频、遗精、妇女带下及消化不良的慢性肠炎，能预防心血管系统的脂肪沉积，保持血管的弹性，防止动脉粥样硬化过早发生，减少皮下脂肪沉积，避免出现肥胖。
玉竹：性平，味甘，玉竹提取类黄酮物质与桑叶提取物脱氧野尻霉素结合形成一种新物质——洗胰清糖素，具有降血糖、血脂、血压等作用，同时能够养阴润燥，生津止渴，用于肺胃阴伤，燥热咳嗽，咽干口渴，内热消渴。
苦瓜：味苦，性寒，具有祛暑涤热、明目、解毒之功效，常用于暑热烦渴，消渴，赤眼疼痛，痢疾，疮痈肿毒，还具有降血糖、抗病毒、抗癌等作用，并能提高人体免疫功能。
决明子：味甘、苦，性性寒，微咸，入肝、肾、大肠经，润肠通便，清肝明目，具有降血压、降血脂、利水通便及滋益肝肾等作用。
玉米须：味甘、淡、性平，具有利尿消肿，清肝利胆的作用，对治疗小便淋沥，黄疸，胆囊炎，胆结石，高血压，糖尿病，乳汁不通的功效。
蛹虫草：新资源食品，虫草酸(甘露醇)入肺肾二经，既能补肺阴，又能补肾阳，主治肾虚，阳痿遗精，腰膝酸痛，病后虚弱，久咳虚弱，劳咳痰血，自汗盗汗等，是唯一的一种能同时平衡、调节阴阳的中药。现代科学论证科茸蛹虫草不仅具有特殊的营养价值，而且有明显的药用价值，具有扶正益气，提高免疫和造血功能，能够调节体内血脂，补肺益肾，提高免疫力、大脑记忆力的功效，健脾安神，对于失眠多梦、神经衰弱有很好的治疗作用。
桑叶：其性寒，气淡，味微苦涩，有清肺润燥、化痰止咳、去热、治盗汗、补肝、清肝明目、治疗头晕眼花、抗疲劳、消肿、止腹痛、除脚气、抑菌、抗炎、利大、小肠及抗衰老等作用。含有强化毛细血管、降低血液黏度的黄酮类成分，另外含有抗体内LDL-脂蛋白氧化的成分，抑具有制脂肪肝的形成、降低血清脂肪和抑制动脉粥样硬化形成的作用，还能预防心肌梗死和脑溢血。桑叶茶可使高脂血症大鼠血清高密度脂蛋白(HDL-C)、HDL-C/TC明显升高(p<0.05)，总胆固醇(TC)、LDL-C、三酰甘油(TG)明显降低(p<0.05)，过氧化脂质(LPO)显著降低(p<0.001)，说明桑叶茶可降低血脂、血糖，软化血管、清除体内过氧化物，对高脂血症血清脂质升高及动脉粥样硬化有抑制作用。
芡实：味甘、涩，性平，归脾、肾经，具有补肾去湿、益肾固精、补脾止泻、除湿止带的功效。
甘草：药食同源，为豆科植物甘草、胀果甘草或光果甘草的干燥根和根茎，具有补脾益气，清热解毒，祛痰止咳，缓急止痛，调和诸药之功效，常用于脾胃虚弱，倦怠乏力，心悸气短，咳嗽痰多，脘腹、四肢挛急疼痛，痈肿疮毒，缓解药物毒性、烈性。
苦荞：性平寒，味甘、苦，富含亚油酸、芦丁、槲皮素、植物固醇、硒、铬、锰，苦荞黄酮，具有降血糖、降血脂、降尿糖、疗胃疾和改善便秘的“三降一疗两通”的食疗营养功能。苦荞糖醇可在人体肠道微生物的作用下降解D——手性肌醇，提高胰岛素的敏感性，从而降低动物和人体的血糖、血脂水平，具有抗菌、抗病毒、清热解毒、益气宽肠之功效。苦荞黄酮不但能有效的活血化瘀、抗栓塞、降血脂、降血压、降低胆固醇、降低血糖，使血液的成份得到净化，而且还可以改善微循环，能降低高的血糖，升高低的血糖，平衡血糖稳定，达到绿色、安全地预防和控制糖尿病及其并发症，是天然的“植物胰岛素”。
本发明的优点在于：
本发明的降血糖固体饮料制作工艺简单，以药食同源为主要原料，并辅以五谷、果蔬，将有益成分全部吃进去，利用率高，温和有效，不仅能有效降低血糖，还能够温补五脏，提高人体免疫力，使糖尿病患者及高血糖人群免受痛苦。
青钱柳叶、辣木叶、山药、玉竹、苦瓜、玉米须、桑叶、苦荞对降低血糖、平衡血糖具有明显的作用。青钱柳被誉为植物界的大熊猫，医学界的第三棵树，富含丰富的皂苷、黄酮、原生态降糖因子链等营养成分，能够全面有效平衡人体糖代谢，从而达到降血糖，逆转并发症的养生效果；辣木叶含有丰富的铁、蛋白质、维生素等营养成分，对降血糖、降脂、降压、抗痛风、抗肿瘤等有很好的效果，长期食用可增强人体免疫功能，并对多种慢性及重大疾病都有极大的改善功效，可辅助治疗肝脏、脾脏、经络等特殊部位的疾病；山药含有丰富的淀粉、蛋白质、无机盐和多种维生素等营养物质，具有降血糖、滋养强壮、助消化的之功效，对脾虚腹泻、肺虚咳嗽、消化不良的慢性肠炎，能预防心血管系统的脂肪沉积，保持血管弹性，预防动脉粥样硬化；玉竹提取类黄酮物质对降血糖、血脂、血压具有重大作用，还能够养胃阴润肺，生津止渴；苦瓜具有降血糖、抗病毒、抗癌等作用，并能提高人体免疫功能；玉米须对治疗糖尿病、小便淋沥、黄疸、胆囊炎、胆结石、高血压具有很好疗效，还有具有消肿，清肝利胆的作用；桑叶可降低血脂、血糖，软化血管、清除体内过氧化物，从而对高脂血症血清脂质升高及动脉粥样硬化有抑制作用，还具有清热解毒、补肝润肺、清胆明目的功效；苦荞是天然的“植物胰岛素”，具有降血糖、降血脂、降尿糖、疗胃疾和改善便秘的“三降一疗两通”的食疗营养功能，苦荞糖醇、提高胰岛素的敏感性，从而降低动物和人体的血糖、血脂水平，使血液的成份得到净化，改善微循环，能降低高的血糖，升高低的血糖，平衡血糖稳，还能抗菌、抗病毒、清热解毒、益气宽肠、活血化瘀、抗栓塞。而决明子、葛根、甘草、蛹虫草、芡实、辅助治疗因高血糖导致的并发症，修复五脏六腑，提高人体免疫力。
血糖的相对平衡与稳定是保障人体健康的基础，血糖长期偏高，容易引发糖尿病，严重者可使人体各种组织器官发生病变，尤其是脾、肾、肝脏、胃、神经以及血管的损害，有效地预防控制血糖，维护身体健康尤为重要。
具体实施方式
以下实施例用于说明本发明，但不用来限制本发明的范围。
实施案例1
一种针对糖尿病人群的固体饮料的制备包括以下步骤：(1)精选青钱柳叶、辣木叶、葛根、山药、玉竹、苦瓜、决明子、玉米须、蛹虫草、桑叶、芡实、甘草、苦荞，洗净、烘焙制熟后进行超微粉碎，获得200目-300目的超微细粉；
(2)将制成的超微细粉，按重量份的比例称取：青钱柳叶30份，辣木叶21份，葛根16份，山药16份，玉竹12份，苦瓜13份，决明子11份，玉米须12份，蛹虫草10份，桑叶8份，芡实9份，甘草6份，苦荞6份，将称量好的超微粉混合好后进行筛分；
(3)将步骤(2)中过筛后的混合粉再经三维混料机进行充分混匀，通过紫外杀菌处理后在无菌环境中进行全密封定量分包装；
(4)将分包装的全密封产品按要求包装成盒，并按照GB/T 29602要求对产品进行检测，合格产品入库储存。
实施案例2
一种针对糖尿病人群的固体饮料料的制备包括以下步骤：(1)精选青钱柳叶、辣木叶、葛根、山药、玉竹、苦瓜、决明子、玉米须、蛹虫草、桑叶、芡实、甘草、苦荞，洗净、烘焙制熟后进行超微粉碎，获得200目-300目的超微细粉；
(2)将制成的超微细粉，按重量份的比例称取：青钱柳28，辣木叶22份，葛根17份，山药17份，玉竹14份，苦瓜14份，决明子13份，玉米须13份，蛹虫草9份，桑叶10份，芡实10份，甘草7份，苦荞7份，将称量好的超微粉混合好后进行筛分；
(3)将步骤(2)中过筛后的混合粉再经三维混料机进行充分混匀，通过紫外杀菌处理后在无菌环境中进行全密封定量分包装；
(4)将分包装的全密封产品按要求包装成盒，并按照GB/T 29602要求对产品进行检测，合格产品入库储存。
实施案例3
一种针对糖尿病人群的固体饮料的制备包括以下步骤：(1)精选青钱柳叶、辣木叶、葛根、山药、玉竹、苦瓜、决明子、玉米须、蛹虫草、桑叶、芡实、甘草、苦荞，洗净、烘焙制熟后进行超微粉碎，获得200目-300目的超微细粉；
(2)将制成的超微细粉，按重量份的比例称取：青钱柳叶26份，辣木叶24份，葛根18份，山药18份，玉竹14份，苦瓜16份，决明子14份，玉米须14份，蛹虫草11份，桑叶11份，芡实11份，甘草9份，苦荞9份，将称量好的超微粉混合好后进行筛分；
(3)将步骤(2)中过筛后的混合粉再经三维混料机进行充分混匀，通过紫外杀菌处理后在无菌环境中进行全密封定量分包装；
(4)将分包装的全密封产品按要求包装成盒，并按照GB/T 29602要求对产品进行检测，合格产品入库储存。
实施案例4
一种针对糖尿病人群的固体饮料的制备包括以下步骤：(1)精选青钱柳叶、辣木叶、葛根、山药、玉竹、苦瓜、决明子、玉米须、蛹虫草、桑叶、芡实、甘草、苦荞，洗净、烘焙制熟后进行超微粉碎，获得200目-300目的超微细粉；
(2)将制成的超微细粉，按重量份的比例称取：青钱柳25份，辣木叶25份，葛根20份，山药20份，玉竹20份，苦瓜18份，决明子15份，玉米须15份，蛹虫草12份，桑叶12份，芡实12份，甘草10份，苦荞10份，将称量好的超微粉混合好后进行筛分；
(3)将步骤(2)中过筛后的混合粉再经三维混料机进行充分混匀，通过紫外杀菌处理后在无菌环境中进行全密封定量分包装；
(4)将分包装的全密封产品按要求包装成盒，并按照GB/T 29602要求对产品进行检测，合格产品入库储存。
对比其他产品及治疗方法，本发明具有以下有益效果：
1本发明采用多种天然草本及五谷为原材料，对降低、平衡血糖具有显著效果，并且能提高人体免疫力，健康安全，无任何化学添加剂；
2本发明配伍科学，饮用安全方便，能够缓解和减轻糖尿病及高血糖人群带来的一系列痛苦，长期坚持饮用可以平衡血糖；
3长期服用本发明，能够修复肾脏、肝脏、脾脏、胃寄肠道等所有创伤，可辅助治疗其他并发症；
4长期服用本发明产品，能够避免糖尿病及高血糖人群遭受因药物带来的痛苦，还能避免患者承受损伤肾脏、肝脏、脾脏等器官的风险，并提高人体免疫力；
5本发明不同于其他降糖袋泡茶及中药，本品有效成分溶解率高，可以直接全部食用，利用率更高，效果更好；
通过对饮食本发明的降糖固体饮料的部分志愿者跟踪调查发现：在观察的60例糖尿病患者中，男：30例，女：30例，年龄：38-66岁，平均年龄：53.6岁，病程5-15年，平均11.5年，检查患者的空腹血糖(FEG)及餐后2h血糖(PBG)及尿糖均符合WTO有关Ⅱ型糖尿病的诊断标准。
按照本发明实施例1-4，每日1至3袋，每袋用100-200mL热水溶解后口服，经过60人的使用，六个月后观察：
实施例1：有48人得到临床控制，有6例效果非常显著，血糖得到控制，减轻了糖尿病患者的痛苦，患者健康状况得到改善。
实施例2：有49人得到临床控制，有5例效果非常显著，血糖得到控制，减轻了糖尿病患者的痛苦，患者健康状况得到改善。
实施例3：有46人得到临床控制，有5例效果非常显著，血糖得到控制，减轻了糖尿病患者的痛苦，患者健康状况得到改善。
实施例4：有47人得到临床控制，有6例效果非常显著，血糖得到控制，减轻了糖尿病患者的痛苦，患者健康状况得到改善。
显然，本发明的上述实施例仅仅是为清楚地说明本发明所作的举例，而并非是对本发明的实施方式的限定。对于所属领域的普通技术人员来说，在上述说明的基础上还可以做出其它不同形式的变化或变动。这里无法对所有的实施方式予以穷举。凡是属于本发明的技术方案所引伸出的显而易见的变化或变动仍处于本发明的保护范围之列。
Claims (2)
1.一种针对糖尿病人群的固体饮料，其特征在于它由下述重量份的原料组成：青钱柳叶25-30，辣木叶20-25份，葛根15-20份，山药15-20份，玉竹12-18份，苦瓜12-18份，决明子10-15份，玉米须10-15份，蛹虫草8-12份，桑叶8-12份，芡实8-12份，甘草5-10份，苦荞6-10份。
2.根据权利1要求所述的一种针对糖尿病人群的固体饮料，特征在于其制作方法包括以下步骤：
(1)按权利要求1精选青钱柳叶、辣木叶、葛根、山药、玉竹、苦瓜、决明子、玉米须、蛹虫草、桑叶、芡实、甘草、苦荞，洗净、烘焙制熟后进行超微粉碎，获得200目-300目的超微细粉；
(2)将步骤(1)制成的超微细粉，按重量份的比例称取：青钱柳叶25-30，辣木叶20-25份，葛根15-20份，山药15-20份，玉竹12-18份，苦瓜12-18份，决明子10-15份，玉米须10-15份，蛹虫草8-12份，桑叶8-12份，芡实8-12份，甘草5-10份，苦荞6-10份，将称量好的超微粉混合好后进行筛分；
(3)将步骤(2)中过筛后的混合粉再经三维混料机进行充分混匀，通过紫外杀菌处理后在无菌环境中进行全密封定量分包装；
(4)将分包装的全密封产品按要求包装成盒，并按照GB/T 29602要求对产品进行检测，合格产品入库储存。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711453774.XA CN109966417A (zh) | 2017-12-28 | 2017-12-28 | 一种针对糖尿病人群的固体饮料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711453774.XA CN109966417A (zh) | 2017-12-28 | 2017-12-28 | 一种针对糖尿病人群的固体饮料 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109966417A true CN109966417A (zh) | 2019-07-05 |
Family
ID=67073996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711453774.XA Pending CN109966417A (zh) | 2017-12-28 | 2017-12-28 | 一种针对糖尿病人群的固体饮料 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109966417A (zh) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110496183A (zh) * | 2019-09-30 | 2019-11-26 | 仲建福 | 一种用于治疗糖尿病的浓缩片及其制备方法 |
| CN112245536A (zh) * | 2020-10-13 | 2021-01-22 | 四川碧康生物科技有限公司 | 一种治疗糖尿病的中草药组合物 |
| CN112471300A (zh) * | 2020-11-24 | 2021-03-12 | 南京博医源健康信息咨询有限公司 | 一种降血压、降血脂、降血糖的药食同源花草茶配方及其制备方法 |
| CN112956574A (zh) * | 2021-04-10 | 2021-06-15 | 张家界锦华中药饮片有限责任公司 | 一种青钱柳复合代用茶及其制备方法 |
| CN112970992A (zh) * | 2021-01-09 | 2021-06-18 | 张家界诺康生态茶业有限公司 | 一种适合糖尿病人的固体饮料及制作方法 |
| CN113499399A (zh) * | 2021-07-30 | 2021-10-15 | 胡巧生 | 一种治疗糖尿病的口服制品及其制备方法 |
| CN113648387A (zh) * | 2021-08-20 | 2021-11-16 | 成都韦斯卡生物科技有限公司 | 一种修护β胰岛细胞、降糖的植萃液及制备方法、应用 |
| CN114794283A (zh) * | 2022-06-02 | 2022-07-29 | 广州市致仁医药科技有限公司 | 一种保健养生茶的高效制备方法 |
| CN115211482A (zh) * | 2022-09-06 | 2022-10-21 | 广州市致仁医药科技有限公司 | 一种清热助消止渴茶及其制备方法 |
| CN115500439A (zh) * | 2021-06-23 | 2022-12-23 | 陕西罗麻丹医药有限公司 | 一种调节血糖血脂的固体饮料及其制备方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106692297A (zh) * | 2017-02-15 | 2017-05-24 | 云南德彩堂生物医药科技有限公司 | 一种辅助降血糖的组合物及其制备方法和应用 |
-
2017
- 2017-12-28 CN CN201711453774.XA patent/CN109966417A/zh active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106692297A (zh) * | 2017-02-15 | 2017-05-24 | 云南德彩堂生物医药科技有限公司 | 一种辅助降血糖的组合物及其制备方法和应用 |
Non-Patent Citations (1)
| Title |
|---|
| 马宇鹏: "《社区糖尿病中西医结合疗法》", 31 October 2015, 中国中医药出版社 * |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110496183A (zh) * | 2019-09-30 | 2019-11-26 | 仲建福 | 一种用于治疗糖尿病的浓缩片及其制备方法 |
| CN112245536A (zh) * | 2020-10-13 | 2021-01-22 | 四川碧康生物科技有限公司 | 一种治疗糖尿病的中草药组合物 |
| CN112471300A (zh) * | 2020-11-24 | 2021-03-12 | 南京博医源健康信息咨询有限公司 | 一种降血压、降血脂、降血糖的药食同源花草茶配方及其制备方法 |
| CN112970992A (zh) * | 2021-01-09 | 2021-06-18 | 张家界诺康生态茶业有限公司 | 一种适合糖尿病人的固体饮料及制作方法 |
| CN112956574A (zh) * | 2021-04-10 | 2021-06-15 | 张家界锦华中药饮片有限责任公司 | 一种青钱柳复合代用茶及其制备方法 |
| CN115500439A (zh) * | 2021-06-23 | 2022-12-23 | 陕西罗麻丹医药有限公司 | 一种调节血糖血脂的固体饮料及其制备方法 |
| CN113499399A (zh) * | 2021-07-30 | 2021-10-15 | 胡巧生 | 一种治疗糖尿病的口服制品及其制备方法 |
| CN113648387A (zh) * | 2021-08-20 | 2021-11-16 | 成都韦斯卡生物科技有限公司 | 一种修护β胰岛细胞、降糖的植萃液及制备方法、应用 |
| CN114794283A (zh) * | 2022-06-02 | 2022-07-29 | 广州市致仁医药科技有限公司 | 一种保健养生茶的高效制备方法 |
| CN115211482A (zh) * | 2022-09-06 | 2022-10-21 | 广州市致仁医药科技有限公司 | 一种清热助消止渴茶及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109966417A (zh) | 一种针对糖尿病人群的固体饮料 | |
| CN101695376B (zh) | 预防糖尿病的保健食品 | |
| CN102511869B (zh) | 红枣生姜浓浆 | |
| CN102784295B (zh) | 一种改善女性更年期综合症的保健制剂配方及其制备方法 | |
| CN102524659A (zh) | 一种具有营养保健功能的粮食配方 | |
| CN102138671A (zh) | 一种人参八珍保健糕的配方和制成方法 | |
| CN102511867B (zh) | 红枣阿胶枸杞浓浆及其生产工艺 | |
| CN103263608A (zh) | 一种排毒养颜的中药原粉 | |
| CN106562428A (zh) | 一种美颜美体膏滋及其制备方法 | |
| CN105533688A (zh) | 一种辅助降血糖保健软胶囊及其制备方法 | |
| CN110051815A (zh) | 一种辅助降血糖食丸及其制备方法 | |
| CN106937741A (zh) | 一种脱脂亚麻籽粉防癌抗癌健康减肥法及其制备方法 | |
| CN101455379A (zh) | 一种适用于糖尿病患者的营养食品及其制备方法 | |
| CN102511876B (zh) | 山楂红枣浓浆及其生产工艺 | |
| CN102511866A (zh) | 红枣阿胶浓浆及其生产工艺 | |
| CN104544084B (zh) | 一种用于糖尿病患者的保健食品 | |
| CN104783174A (zh) | 一种纯天然营养免疫保健固体饮料的配制方法 | |
| CN101991110A (zh) | 野生灵芝系列食品 | |
| CN100382832C (zh) | 一种用于改善女性更年期症状的保健食品 | |
| CN102511868A (zh) | 一种添加维生素的红枣阿胶浓浆 | |
| CN106036384A (zh) | 一种适合糖尿病患者食用的养生粥及其制备方法 | |
| CN106262857A (zh) | 一种营养食品及其制备方法 | |
| CN114748583A (zh) | 一种滋补养生的中药药酒 | |
| CN105638961A (zh) | 一种含有苎麻叶的黑茶组合物及制备方法 | |
| CN104825379A (zh) | 减少黑色素沉积的美白焕肤晚霜及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20200603 Address after: 430040 No.11 Yintan Road, Jiangjun Road Street office, Dongxihu District, Wuhan City, Hubei Province (12) Applicant after: Wuhan wansongtang Biomedical Technology Co.,Ltd. Address before: 441300 Suizhou Zengdou Economic Development Zone Hubei Hui Biological Park Applicant before: SUIZHOU WANSONGTANG KANGHUI HEALTH PRODUCTS Co.,Ltd. |
|
| TA01 | Transfer of patent application right | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190705 |
|
| RJ01 | Rejection of invention patent application after publication |